Skip to main content

Table 2 Average sequencing read coverage for all drug resistance mutations identified in the ALIVE cohort

From: Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq

Gene product

Drug resistance mutation*

Ave. sequencing read coverage

PR

L10IFVC

297

 

V11I

294

 

G16E

1022

 

K20RMITV

1917

 

L24I

1039

 

D30N

2169

 

L33FIV

3140

 

M36LIV

3639

 

M46I/L

2609

 

I50L/V

3895

 

F53LY

1213

 

I54VTALM

2122

 

D60E

3065

 

I62V

3198

 

L63P

3346

 

I64LMV

2635

 

A71VITL

3800

 

G73CSTA

3045

 

V82ATFSL

3300

 

L89VIM

4199

 

L90M

4982

 

I93LM

5850

RT

M41L

5014

 

A62V

4941

 

K70R

4324

 

V75I

10460

 

V77I

4787

 

V90I

4177

 

K103N

6048

 

V106A/M/I

6492

 

V108I

7424

 

E138KAGQR

7401

 

M184V/I

5906

 

Y188LHC

5283

 

G190ASE

4708

 

P225H

5764

 

M230LI

8668

IN

S147G

3123

  1. *Boldface mutations are major drug resistance mutations, non-boldface mutations are accessory mutations.